Related references
Note: Only part of the references are listed.Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
Helene Le Ribeuz et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
Diazoxide for Neonatal Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension
Shoshana Newman-Lindsay et al.
CHILDREN-BASEL (2023)
Pulmonary Hypertension and Necrotizing Enterocolitis in Neonates Treated with Diazoxide
Mounya Duggal et al.
AMERICAN JOURNAL OF PERINATOLOGY (2023)
SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension
Helene Le Ribeuz et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)
The IUPHAR/BPS guide to PHARMACOLOGY in 2022: curating pharmacology for COVID-19, malaria and antibacterials
Simon D. Harding et al.
NUCLEIC ACIDS RESEARCH (2022)
Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia
Suresh Chandran et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2022)
Novel KDM6A Kabuki Syndrome Mutation With Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension Requiring ECMO
Maria Salguero et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2022)
Exploring diazoxide and continuous glucose monitoring as treatment for Glut1 deficiency syndrome
Santhi N. Logel et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
The danger of diazoxide in the neonatal intensive care unit
Jay Desai et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2021)
Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy
Rachel T. Sullivan et al.
PULMONARY CIRCULATION (2021)
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
Jason Weatherald et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Pulmonary Hypertension Following Increased Dosing of Diazoxide in an Infant
Yuji Ohnishi et al.
INTERNATIONAL HEART JOURNAL (2020)
Characterization of rare ABCC8 variants identified in Spanish pulmonary arterial hypertension patients
Mauro Lago-Docampo et al.
SCIENTIFIC REPORTS (2020)
Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension
Helene Le Ribeuz et al.
BIOMOLECULES (2020)
Possible New Strategies for the Treatment of Congenital Hyperinsulinism
Jelena Sikimic et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Rate of Serious Adverse Events Associated with Diazoxide Treatment of Patients with Hyperinsulinism
Paul Thornton et al.
HORMONE RESEARCH IN PAEDIATRICS (2019)
Pulmonary Hypertension and ATP-Sensitive Potassium Channels Paradigms and Paradoxes
Conor McClenaghan et al.
HYPERTENSION (2019)
Structure-Activity Relationships, Pharmacokinetics, and Pharmacodynamics of the Kir6.2/SUR1-Specific Channel Opener VU0071063
Sujay Kharade et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Diazoxide-induced pulmonary hypertension in hyperinsulinaemic hypoglycaemia: Recommendations from a multicentre study in the United Kingdom
Suet Ching Chen et al.
CLINICAL ENDOCRINOLOGY (2019)
Novel risk genes and mechanisms implicated by exome sequencing of 2572 individuals with pulmonary arterial hypertension
Na Zhu et al.
GENOME MEDICINE (2019)
Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension
Ly Tu et al.
CIRCULATION RESEARCH (2019)
Identification of genetic factors underlying persistent pulmonary hypertension of newborns in a cohort of Chinese neonates
Xu Liu et al.
RESPIRATORY RESEARCH (2019)
Pulmonary hypertension occurring with diazoxide use in a preterm infant with hypoglycemia
Ranjit Kylat
DRUG HEALTHCARE AND PATIENT SAFETY (2019)
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart et al.
NUCLEIC ACIDS RESEARCH (2018)
Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus Results From the French Pulmonary Hypertension Registry
Eric Hachulla et al.
CHEST (2018)
Prevalence of Adverse Events in Children With Congenital Hyperinsulinism Treated With Diazoxide
Adriana Herrera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Loss-of-Function ABCC8 Mutations in Pulmonary Arterial Hypertension
Michael S. Bohnen et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Jason Weatherald et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Population Pharmacokinetics of Diazoxide in Children with Hyperinsulinemic Hypoglycemia
Rika Kizu et al.
HORMONE RESEARCH IN PAEDIATRICS (2017)
Development of Pulmonary Hypertension During Treatment with Diazoxide: A Case Series and Literature Review
Matthew R. Timlin et al.
PEDIATRIC CARDIOLOGY (2017)
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension
Christophe Guignabert et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Chemotherapy-Induced Pulmonary Hypertension Role of Alkylating Agents
Benoit Ranchoux et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension
Lu Long et al.
NATURE MEDICINE (2015)
A Patient With Cantu Syndrome Associated With Fatal Bronchopulmonary Dysplasia and Pulmonary Hypertension
Jae Young Park et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2014)
Direct Activation of β-Cell KATP Channels with a Novel Xanthine Derivative
Rene Raphemot et al.
MOLECULAR PHARMACOLOGY (2014)
Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension Results of the Randomized IMPRES Study
Marius M. Hoeper et al.
CIRCULATION (2013)
Multiplicity of effectors of the cardioprotective agent, diazoxide
William A. Coetzee
PHARMACOLOGY & THERAPEUTICS (2013)
Cantu Syndrome Is Caused by Mutations in ABCC9
Bregje W. M. van Bon et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
David Montani et al.
CIRCULATION (2012)
Novel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
R. Harpaz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Dominant missense mutations in ABCC9 cause Cantu syndrome
Magdalena Harakalova et al.
NATURE GENETICS (2012)
Pulmonary hypertension and reopening of the ductus arteriosus in an infant treated with diazoxide
Fatma Demirel et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2011)
Inwardly Rectifying Potassium Channels: Their Structure, Function, and Physiological Roles
Hiroshi Hibino et al.
PHYSIOLOGICAL REVIEWS (2010)
Pulmonary Hypertension Secondary to Partial Pulmonary Venous Obstruction in a Child With Cantu Syndrome
Daisuke Kobayashi et al.
PEDIATRIC PULMONOLOGY (2010)
Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
Dincer Yildizdas et al.
ADVANCES IN THERAPY (2008)
Immunosuppressive therapy in lupus- and mixed connective tissue disease-associated pulmonary arterial hypertension
Xavier Jais et al.
ARTHRITIS AND RHEUMATISM (2008)
Sulfonylurea receptor-dependent and -independent pathways mediate vasodilation induced by ATP-sensitive K+ channel openers
Adebowale Adebiyi et al.
MOLECULAR PHARMACOLOGY (2008)
Mitochondria-derived reactive oxygen species dilate cerebral arteries by activating Ca2+ sparks
Q Xi et al.
CIRCULATION RESEARCH (2005)
KATP channels and preconditioning:: A re-examination of the role of mitochondrial KATpchannels and an overview of alternative mechanisms
PJ Hanley et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
A case of severe diazoxide toxicity
P Silvani et al.
PEDIATRIC ANESTHESIA (2004)
Potent and selective activation of the pancreatic beta-cell type KATP channel by two novel diazoxide analogues
M Dabrowski et al.
DIABETOLOGIA (2003)
Functional involvement of sulphonylurea receptor (SUR) type 1 and 2B in the activity of pig urethral ATP-sensitive K+ channels
T Yunoki et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
The molecular composition of K(ATP) channels in human pulmonary artery smooth muscle cells and their modulation by growth
Y Cui et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
C-terminal tails of sulfonylurea receptors control ADP-induced activation and diazoxide modulation of ATP-sensitive K+ channels
T Matsuoka et al.
CIRCULATION RESEARCH (2000)
ATPase activity of the sulfonylurea receptor:: a catalytic function for the KATP channel complex
M Bienengraeber et al.
FASEB JOURNAL (2000)
Pharmaco-topology of sulfonylurea receptors -: Separate domains of the regulatory subunits of KATP channel isoforms are required for selective interaction with K+ channel openers
AP Babenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
